• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Valiant Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
123.33 -3 (-1.99%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    123.33

  • Today’s High

    123.33

  • Open

    123.33

  • Perv Close

    125.84

  • 52W Low

    49.51

  • 52W High

    141.38

Key Indicators

  • P/E(TTM)

    46.25

  • Mar.Cap (₹Cr.)

    669.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    60.88

  • Debt-Equity Ratio

    -1.99

  • AGM Date

    03-Nov-2026

  • EPS

    2.67

  • P/E Ratio

    46.25

Financials Ratios

  • Debt-Equity Ratio

    0.41

  • Mar.Cap (₹Cr.)

    669.84

  • RONW (%)

    -1.71

  • ROCE (%)

    -1.63

Score Board

  • Equity (₹ in Cr.)

    54.31

  • BV (₹)

    58.90

  • Sales( ₹ in Cr.)

    217.04

  • NP (in Cr.)

    4.83

  • NP Var(%)

    203.0

  • Div%

    0.0

  • CPS (₹)

    1.30

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    684.34

  • 52 Week High

    141.38

  • 52 Week Low

    49.51

  • Price BSE

    126.0

  • Price NSE

    126.00

  • Market Capital( in Cr.)

    684.34

  • P/C Ratio

    96.40

  • P/E Ratio

    141.60

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 217.04 133.36 182.05 333.91 291.52 182.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 217.04 133.36 182.05 333.91 291.52 182.37
Other Income 2.89 5.43 9.68 4.86 1.95 1.41
Stock Adjustments -0.21 -3.86 1.14 0.24 1.97 0.13
Total Income 219.72 134.93 192.87 339.01 295.44 183.91
EXPENDITURE :            
Raw Materials 186.25 112.19 168.66 276.76 236.19 120.53
Power and Fuel Cost 7.41 5.94 8.33 7.37 4.38 3.17
Employee Cost 5.00 4.39 4.31 4.61 3.06 2.71
Other Manufacturing Expenses 4.45 3.65 6.07 4.86 3.70 3.55
Selling and Administration Expenses 4.59 2.73 2.76 4.09 2.76 2.25
Miscellaneous Expenses 1.95 5.28 1.46 1.37 1.09 0.29
Employee Benefit Expenses 5.00 4.39 4.31 4.61 3.06 2.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 209.65 134.18 191.59 299.06 251.18 132.50
Operating Profit 10.07 0.76 1.28 39.95 44.26 51.41
Interest 0.26 0.18 0.08 0.25 0.07 1.78
Gross Profit 9.81 0.58 1.20 39.70 44.19 49.63
Depreciation 2.26 2.02 1.95 1.56 2.49 2.61
Profit Before Tax 7.55 -1.44 -0.75 38.14 41.70 47.02
Current Tax 1.66 0.06 -0.98 8.80 14.47 16.46
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.34 0.65 -0.11 0.34 -0.26 -0.03
Reported Net Profit 5.55 -2.15 0.34 29.00 27.50 30.59
Extraordinary Items 0.71 2.55 3.20 0.00 0.03 0.00
Adjusted Net Profit 4.84 -4.70 -2.86 29.00 27.47 30.59
Adjustment below Net Profit 0.00 0.00 0.18 0.03 -48.92 19.37
P & L Balance brought forward 49.96 52.11 51.59 22.56 78.08 28.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 34.10 0.00
P & L Balance carried down 55.51 49.96 52.11 51.59 22.56 78.08
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.02 -0.49 0.08 8.91 16.89 29.14
Earnings Per Share(Adj)-Unit Curr 1.02 -0.45 0.07 - - -
Book Value 58.87 53.94 54.52 30.86 43.89 84.36
Book Value(Adj)-Unit Curr 58.87 50.06 50.60 - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 25,437,500 46.84 25,437,500 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,263,987 28.10 15,263,987 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 40,701,487 74.94 40,701,487 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 35,323 0.07 35,323 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 44,927 0.08 44,927 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 80,250 0.15 80,250 3
2] Non Institution
Bodies Corporate 1,725,450 3.18 1,725,450 66
Clearing Members 201,312 0.37 201,312 14
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 159,512 0.29 159,512 112
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 840,699 1.55 840,699 543
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,755,187 8.76 4,755,187 56
Individuals holding nominal share capital up to Rs. 1 lakh 5,743,137 10.57 5,743,137 13,804
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,530,763 24.91 13,530,763 14,606
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 54,312,500 100.00 54,312,500 14,618

Company Background

Valiant Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Valiant Laboratories Ltd
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017

  • Incorporation Year

    2021

  • Registered Office

    104 Udyog Kshetra Mulund
    Goregaon Link Rd Mulund West, Mumbai,
    Maharashtra-400080

  • Telephone

    +91 22 49712001

  • FAX

  • Chairman

    Mulesh Manilal Savla

  • Managing Director

    Santosh S. Vora

  • Company Secretary

    Akshay Gangurde

  • Auditor

    Raman S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Valiant Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Valiant Laborato 123.50 219.94 217.04 46.25 2.53
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77